Articles related to LIPID MANAGEMENT

Clinical evidence shows that as people age, their bodies become less efficient at clearing cholesterol from the bloodstream, necessitating more aggressive monitoring and management strategies.

Analysis of objective biomarkers in blood samples reveals that individuals with the highest levels of omega-3 or omega-6 fatty acids demonstrated 20% lower cancer mortality rates compared to those with the lowest levels.

Analysis of 285,680 patients shows a 1.03-1.38% reduction in cumulative mortality with rosuvastatin compared to atorvastatin, alongside varying risks for cardiovascular events, liver outcomes, and diabetes.

N=1 science empowers patients to become “citizen scientists,” experimenting and refining their health choices to find what works best for their own bodies.

Bempedoic acid reduced major adverse cardiovascular events by 13% compared to placebo in statin-intolerant patients, with efficacy comparable to statins when normalized for LDL-C reduction.

Recent evidence suggests that limiting foods high in saturated and trans fats may be more beneficial for cholesterol management than focusing solely on dietary cholesterol intake.